Back to Search
Start Over
965: EFFICACY AND SAFETY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE TYROSINE KINASE 2 INHIBITOR, IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: 12-WEEK RESULTS FROM THE PHASE 2 LATTICE-UC STUDY
- Source :
- Gastroenterology. 162:S-226
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Hepatology
Gastroenterology
Subjects
Details
- ISSN :
- 00165085
- Volume :
- 162
- Database :
- OpenAIRE
- Journal :
- Gastroenterology
- Accession number :
- edsair.doi...........e9f7930c24aacd658e9a517d6172044d
- Full Text :
- https://doi.org/10.1016/s0016-5085(22)60544-4